Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4320973 | Neuron | 2014 | 4 Pages |
Abstract
We have made little recent progress developing effective new treatments for neuropsychiatric and neurodevelopmental disorders. Novel molecular mechanisms have been identified, but have not translated into the clinic. We suggest an alternative: combinations of treatments targeting different aspects of final common pathways in biologically defined clinical subgroups. This will require integrated translational neuroscience and international public-private partnerships.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Declan G.M. Murphy, Michel Goldman, Eva Loth, Will Spooren,